Back to search

Ireland· IE-PA-EU/1/21/1561/023-025

Verquvo 10 mg film-coated tablets

A vericiguat product containing vericiguat, registered in Ireland by Bayer AG. The same ATC class is registered in 15 of our 19 countries.

ATC C01DX22

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedVerquvo 10 mg film-coated tabletsATCC01DX22REGISTER NO.IE-PA-EU/1/21/1561/02…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Vericiguat is registered in 15 of 19 countries.

Countries holding a registration under ATC C01DX22 (vericiguat), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 9 of them publish a price we can compare per daily dose

Vericiguat · ATC C01DX22

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vericiguat costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vericiguat · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$12.83
  • ES Spain$9.99
  • IT Italy$9.50
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Vericiguat
Manufacturer
Bayer AG
Country
Ireland (IE)
ATC code
C01DX22
ATC class
Vericiguat
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/21/1561/023-025

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vericiguat in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vericiguat products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Verquvo
  • Liechtenstein · Verquvo
  • Norway · Verquvo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/74f2d2e5-e642-400f-89e8-5a1767ed3ecf
GET /v1/drugs/74f2d2e5-e642-400f-89e8-5a1767ed3ecf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "C01",
    "C01DX22"
  ],
  "strength": null,
  "pa_number": "EU/1/21/1561/023-025",
  "substances": [
    "Vericiguat"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "16/07/2021",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about vericiguat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.